Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;24(4):569-74.
doi: 10.1007/s00540-010-0942-1. Epub 2010 May 18.

Hydrogen-rich saline solution attenuates renal ischemia-reperfusion injury

Affiliations

Hydrogen-rich saline solution attenuates renal ischemia-reperfusion injury

Chihiro Shingu et al. J Anesth. 2010 Aug.

Abstract

Purpose: Renal ischemia-reperfusion (I/R), an important cause of acute kidney injury, is unavoidable during various types of operations, including renal transplantation, surgical revascularization of the renal artery, partial nephrectomy, and treatment of suprarenal aortic aneurysms. Exacerbation of I/R injury is mediated by reactive oxygen species (ROS). A recent study has shown that hydrogen has antioxidant properties. In this study, we tested the hypothesis that a hydrogen-rich saline solution (HRSS) attenuates renal I/R injury in a rodent model.

Methods: Rats were treated with an intravenous injection of HRSS or control saline solution followed by renal I/R. After 24 h of treatment, we performed a histological examination and transmission electron microscopy, and measured serum levels of 8-OHdG.

Results: Histological analysis revealed a marked reduction of interstitial congestion, edema, inflammation, and hemorrhage in renal tissue harvested 24 h after HRSS treatment compared to saline administration. Renal I/R injury, which led to altered mitochondrial morphology, was also inhibited by HRSS. Furthermore, serum 8-OHdG levels were significantly lower in rats treated with HRSS and subjected to renal I/R.

Conclusions: These protective effects were likely due to the antioxidant properties of HRSS. These results suggest that HRSS is a potential therapeutic candidate for treating various I/R diseases.

PubMed Disclaimer

References

    1. J Am Soc Nephrol. 2006 Jun;17(6):1503-20 - PubMed
    1. Nat Clin Pract Nephrol. 2005 Dec;1(2):87-97 - PubMed
    1. Lancet. 2004 Nov 13-19;364(9447):1814-27 - PubMed
    1. Biochem Biophys Res Commun. 2007 Sep 28;361(3):670-4 - PubMed
    1. Biochim Biophys Acta. 1998 Aug 14;1407(2):99-108 - PubMed

Publication types

LinkOut - more resources